AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 193 filers reported holding AMICUS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $13,532,000 | +68.7% | 1,389,344 | +38.9% | 0.60% | +57.0% |
| Q3 2019 | $8,020,000 | +7.1% | 1,000,000 | +66.7% | 0.38% | +12.7% |
| Q2 2019 | $7,488,000 | +175.3% | 600,000 | +200.0% | 0.34% | +218.9% |
| Q1 2019 | $2,720,000 | -54.9% | 200,000 | -50.0% | 0.11% | -62.4% |
| Q3 2017 | $6,032,000 | – | 400,000 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |